Our Mission

Provide best-in-class conduct of clinical trials and consulting in reimbursement and regulatory affairs to biomedical companies, globally.

Winner of the 2022 Globe Award

Every year, the Georgia Department of Economic Development awards Georgia companies who have expanded sales to new international markets in the previous year. This year, TAMM Net was recognized with a 2022 Globe Award for it's work with international clients in the medical industry.

See the Award | See the Commendation

Just ask our clients

We customize solutions that fit the needs of needs of all our clients, and strive to ensure the success of each and every one of them

Learn how TAMM Net can help your medical miracle blossom

Quality & Regulatory

TAMM Net develops the regulatory strategy, filings, and compliance auditing that will get you on the right path.

Learn More

Managed Markets & Reimbursement

Analysis, planning, execution, coding, payer assessments... Everything you need to manage managed markets.

Learn More

Reimbursement Support Call Center Activities

Prior authorizations, reimbursement guides, verification, and sales force support are just some of our offerings.

Learn More


We won't only help you develop a clinical plan, we'll even integrate it with regulatory and reimbursement requirements.

TAMM Net Services Flyer

See Our Services Flyer

English Deutsch Italiano

Our Process Ensures Predictable Outcomes

A multi-step process ensures we learn all we can about your needs and provide consistent, high-quality product.

Discovery and Requirements

8-12 step process.

It is vital to take the time and effort required to completely capture the knowledge you have about your product and therapeutic area. Asking the right questions at this stage is critical for helping to prevent needless expenditures and inefficiencies.

When we perform claims analysis there are many different databases from which to collect claims data. By asking our clients detailed questions about the purpose of the analysis and their knowledge of where the procedures are performed and by whom, we can propose the most appropriate resources.

Planning (GAP Analysis)

11-18 step process

For a recent cellular therapy client, performing a gap analysis was critical in their initial fundraising. By identifying exactly what additional information was needed to obtain an IND, they presented successfully to investors.


Reimbursement is its own strategic morass. By creating an overall portfolio clinical development plan, we can anticipate any resistance that may be brought by medical societies or payers. For a client in a very competitive space with huge existing competition, this enabled us to plan a sequential new coding strategy to minimize resistance.

Implementation & Execution (Clinical Development Plan)

9 step process

A carefully laid plan leads to a systematic execution and the ability to adapt when regulatory bodies change their minds. Our internal processes ensure that execution is both accurate and timely.


9-18 step process

Delivery is another dialogue. We typically deliver a draft to ensure that we are capturing everything in the statement of work. Once all parties agree on the draft final versions are produced.

“TAMM Net has been a valuable partner helping us navigate reimbursement and regulatory. They coordinated our activities with CMS including a successful C-code application and connected us with policy representatives in medical societies. TAMM Net’s regulatory team efficiently wrote and submitted our successful 510(k) application for CivaSheet. They have helped our company meet key milestones. We continue to work with TAMM Net because of the professionalism and effectiveness they bring to each task.” —Susan Babcock

Close & Continuation

6-8 step process

We engage with our clients early in the development process and stay connected after any project is done. For most of our clients, our engagement is an ongoing partnership. We want to make sure that if there are any questions about our work, we are there to answer them as they arise. Of course, this also leads to many referrals, for which we are grateful.

Our Values

Our values are a reflection of the work we do for you.

Grateful to our clients and colleagues
Reliable in our deeds and actions
Accountable to all
Unwavering Integrity
Long-term Outlook

Leadership Team

TAMM Net is led by a world-class team of experienced biomedical professionals

Arthur F. Spalding

Arthur F. Spalding


Mr. Spalding has over 25 years’ experience in pharmaceuticals and medical devices directing various functions including: reimbursement, clinical trial design and facility recruitment, distribution, managed markets, market research, hospital sales, forecasting, and sales operations. Mr. Spalding held management and director level positions at various companies including Parke-Davis, Pfizer, Solvay, and Columbia Laboratories. In 2009, Mr. Spalding started TAMM Net, Inc., a consultancy servicing biomedical manufacturers. TAMM Net has helped manufacturers: conduct clinical trials; gain reimbursement; and gain marketing approvals/clearances. Mr. Spalding holds a B.S. in Chemistry from Union College, Schenectady, NY and an MBA in Health Administration from Temple University in Philadelphia.

Janan VanOsdell

Janan Van Osdell, MBA, MHSA

Director, Clinical Research

Ms. Van Osdell has over 20 years of experience in various aspects of healthcare and the pharmaceutical industry resulting in a unique blend of business and science. She considers herself a life-long learner and enjoys learning about new technologies in all therapeutic areas. She identifies with the goals of the clients and personally enjoys and celebrates our clients’ successes.

Janan loves being involved with clinical research “as much as some people love golf!” She finds the technologies that TAMM Net is involved with to be extremely fascinating and exciting. She also enjoys meeting the dynamic people behind these technologies, from the inventors of devices and pharmacologists in the lab, to the dynamic CEOs who are busting through obstacles to get these new technologies approved/cleared by the FDA and into the health care market.

Janan has a work background starting in academic research (Emory University—Oral Health Research), and then in pharmaceuticals (Procter & Gamble, Solvay Pharmaceuticals, Abbott Labs); and she is one of the original consultants with TAMM Net. Her career roles include Clinical Research Consultant, Clinical Trial Manager, Clinical Research Medical Writer, Educational Marketing, (including Continuing Medical Education materials), Market Research, and Professional Relations.

Janan received her BS in Oral Health Sciences from LSU Health Sciences Center in New Orleans. In one of her adventures into learning something new, she ventured into business law and accounting at LSU Baton Rouge and became a Certified Public Accountant. She earned both MBA and MHSA (Health Services Administration) degrees from Xavier University in Cincinnati. She also recently completed 4 semesters of Physics from Agnes Scott College in Atlanta in their adult learning program.

Betty Lou Anderson

Betty Lou Anderson

Director of Global Business Development

Mrs. Betty Lou Anderson brings over 20 years of US healthcare sales experience to TAMM Net. She has a depth of experience working in a variety of non-clinical and clinical sales roles within pharmaceutical and biotech companies, hospitals, physician practices, and health systems. These roles have included working closely with specialty physicians, mid-levels, scientists, pathologists, laboratory and hospital personnel, pharmacists, and C-level executives. Her experience as a Business Development professional encompasses collaborating with healthcare professionals across many different therapeutic areas. Throughout her career, Betty Lou was recognized with President’s Club for outstanding business results, and mentorship. Prior to working for TAMM Net, she was working for the world’s largest contract research organization (CRO) Covance, a division of LabCorp. She has a breadth of knowledge in Women’s Health where she spent a large portion of her sales career with Wyeth Pharmaceutical company and Optum Healthcare. In the last three years, she has worked with a variety of small to mid-size companies in medical devices, diagnostics, and therapeutics supporting their journey to market with services in the regulatory and reimbursement arena. She manages a variety of projects while prospecting for new clients. This experience has enabled her to empathize with the struggles that CEO’s, scientists, and innovators developing new treatments and innovations face in balancing funds while bringing their medical miracle to market. Her network is vast across the industry, and she is a connector of people! Betty Lou holds a B.S. in Communication Arts from Georgia Southern University.

Pamela McColl

Pamela McColl

Mrs. McColl has over 15 years working in regulated industries including banking, medical devices, and biologics. Her technical expertise includes FDA, ISO 13485, Notified body, American Association Tissue Banking, ISO 13485 Auditor for a Registrar, and various other international audits. She has written numerous Medical Device Quality Systems from beginning to end for ISO Certification. Assisted companies in providing their internal audit, providing gap analysis for QMS as well as reviewing, revising their Quality System to be audited by a notified body for ISO Certification. Well over 100 audits (including international audits) of suppliers, manufacturers, ISO, sterilizers, and tissue recovery organizations combined. As a compliance auditor at CryoLife she became an expert at good tissue practices while performing internal and supplier audits, and meeting many other corporate objectives. She has participated in several FDA audits and assisted in alleviating warning letters. She directed multiple corrective action and preventive action (CAPA) programs.

Jeffrey P. Bush

Jeffrey P. Bush, CT (ASCP), MBA

With over 30 years of experience in diagnostic, medical device and clinical laboratory industries, Jeff Bush applies his expertise to the development and implementation of market access and business development strategies as they intersect at the point of healthcare product commercialization. He has a proven track record as a leader across the industry managing substantial portfolios within start-up, mid-sized, and Fortune 200 companies.

Jeff served as Vice President, Business Development at Genetesis. Prior to Genetesis, Jeff was Vice President, Payer Markets and Reimbursement at Assurex Health. During his tenure, he led the company to coverage and payment by Medicare and other payers fueling the company's rapid growth from <$10M per year revenue to nearly $120M per year trajectory over 4 years (>86% CAGR). Jeff was a key member of the Assurex executive leadership team, and he also held responsibility for the company's health economic analysis development plan leading to an AJMC cost-effectiveness publication. Prior to Assurex, Jeff was the Worldwide Director of Corporate Reimbursement for Becton, Dickinson and Company (BD) where he was responsible for building the company’s worldwide function focused on coding, coverage, and payment for the company’s products in the United States and overseas. Jeff represented BD within the AdvaMed trade association Board Payment Committee, was a well-recognized leader within the organization, and twice chaired the Diagnostics Payment Working Group (DPWG), including development and oversight for the landmark “Value of Diagnostics” report commissioned by the association in 2005.

Jeff earned a Bachelor’s degree in Chemistry from California State University, a certificate in Cytotechnology from Loma Linda University and an MBA from Colorado State University.

Contact Us

Area of Interest

Alternatively, email us at info@tammnet.com

Our Affiliates